The Lancet3d
A step towards more physiological glucocorticoid dosing in congenital adrenal hyperplasia
On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...
Compound mimics cannabis for pain relief without the side effects: Mouse study points to effective opioid alternative
Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly ...
Medscape18d
Inhaled Morphine for Palliation of Dyspnea in End-stage Cystic Fibrosis
Janahi and colleagues [14] reported the successful use of nebulized morphine sulfate 2 mg, dexa-methasone 2.5 mg, and 0.9% sodium chloride injection 2.5 mL administered every four hours as needed ...
The Lancet21d
Navigating the androgen receptor landscape in triple-negative breast cancer
1 As current standard-of-care options for triple-negative breast cancer are focused on chemotherapy and immunotherapy, exploring androgen receptor (AR)-targeted therapy offers new avenues for patients ...
Neuroscience News24d
How Ketamine Binds to Brain Receptors to Alter Mood
Summary: New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D. Scientists used electron cryo-microscopy to capture how ketamine binds ...